🕵️ Alzamend Neuro, Inc. ($ALZN)
SEC insider & ownership activity, last 12 months · CIK 1677077 · every row links its SEC filing
Over the last 12 months insiders sold $1.6M against $111K of open-market buying. Milton C. Ault III sold $1.6M (Sep–Aug). 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Aug 3, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $111K (2 lots) · 3 sellers, $1.6M (20 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Milton C. Ault III | 2 | $111K | 18 | $1.6M | Aug 26, 2026 |
| William B. Horne | 0 | – | 1 | $7K | Dec 19, 2025 |
| McGrath Lynne Fahey | 0 | – | 1 | $69 | Oct 23, 2025 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Aug 3, 2026 | filing ↗ |
| Delisting notice (3.01) | Aug 3, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 3, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Aug 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 3, 2026 | filing ↗ |
| Other events (8.01) | Jul 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 17, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 20, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Other events (8.01) | Nov 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 18, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Oct 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 14, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 9, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 25, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 25, 2025 | filing ↗ |